Obesity Weekly News - July 22nd 2025
Obesity Update: CGX-926 Oral Debut, 18% Weight Loss from KAI-9531, Vivani’s…
Obesity Weekly News - July 15th 2025
Obesity Update: Wegovy’s 7.2mg Bid, Rhythm’s Oral Win, TRPV1 Breakthrough &…
Obesity Weekly News - July 8th 2025
China’s Dual GCG/GLP-1 Breakthrough, Innogen’s 2026 Goal, Zepbound's Korea…
Obesity Weekly News - July 1st 2025
Fractyl’s Gene Therapy Breakthrough, Verdiva’s Oral GLP-1 Pipeline, Viking’s…
Obesity Weekly News - June 24th 2025
Eccogene’s Oral GLP-1 Debut, Novo’s 24% Weight Loss Win, Lilly’s Q3 Reveal…
Obesity Weekly News - June 17th 2025
Obesity 🚨 Breakthroughs in Obesity Drug Development You Need to Know! In this…
Obesity Weekly News - June 10th 2025
Obesity Advancements: Arrowhead’s RNAi Debut, Lilly’s $870M Bet, Novo’s Triple…
Obesity Weekly News - June 3rd 2025
Obesity Advancements: Regeneron’s Triplet Breakthrough, $2B Hansoh Deal,…
Obesity Weekly News - May 27th 2025
Obesity Advancements: Ascletis’ Combo Trial, Mazdutide’s NEJM Breakthrough,…
Obesity Weekly News - May 20th 2025
Latest Obesity Updates: Zealand’s Obesity Strategy, $2.2B Novo Deal, China’s…
Obesity Weekly News - May 13th 2025
30% Weight Loss, Zepbound vs Wegovy & Affordable Semaglutide Deals In this…
Obesity Weekly News - May 6th 2025
Obesity Latest News: GLP-1 Pill Update, Discount Wars & Pharma Shakeups In…
